Evoke Pharma's total assets for Q3 2024 were $14.15M, an increase of 16.62% from the previous quarter. EVOK total liabilities were $9.77M for the fiscal quarter, a 3.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.